Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01328782 · ClinicalTrials.gov registry record · NA
The Post-Operative Pain Management of Pediatric Supracondylar Elbow Fractures
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT01328782 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 124 participants.
The verdict
NCT01328782, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
The goal of this study is to compare different ways of treating pain after surgery. This research study involves subjects who have a supracondylar elbow fracture and need surgery. This type of fracture occurs when the humerus (upper arm bone) is broken just above the elbow. Like any other surgery, you can expect that you will feel pain in the hours or days after the operation. Currently, despite the common occurrence of this surgery, there is not a standard way to treat and or prevent any of the pain afterwards. At this hospital, oral (take by mouth) pain medicine is commonly used to treat pain after this surgery. In this study, pain will be treated in one of the following ways: 1. with oral pain medication 2. with oral pain medicine and an intraarticular shot (a shot into the elbow joint) of bupivacaine (a "numbing" drug) or 3. with oral pain medicine and an intraarticular shot of ropivacaine (another "numbing" drug). The shots will be given during surgery. Your participation will help us find out which of these three pain control methods works the best. The correct dosages of all drugs will be safely prescribed by the doctor on an individual basis and all drugs will be used under the careful watch of your attending physician. All the drugs used this study are approved by the FDA for use in adults but they are not specifically approved for use in children. However, nearly 7 out of every 10 drugs approved for adults are not specifically approved by the FDA for use in children. All drugs used in this study will be used in a way that is considered to be safe and reasonable by the Children's Hospital.
Interventions
- DRUG Bupivacaine 0.25%
- DRUG Oxycodone with Acetaminophen
- DRUG Ropivacaine 0.20%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01328782
The ClinicalTrials.gov registry entry for NCT01328782 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Bupivacaine 0.25% is the first listed.
NCT01328782 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01328782 about?
NCT01328782 is a clinical study titled "The Post-Operative Pain Management of Pediatric Supracondylar Elbow Fractures". The goal of this study is to compare different ways of treating pain after surgery. This research study involves subjects who have a supracondylar elbow fracture and need surgery. This type of fracture occurs when the humerus (upper arm bone) is broken just above the elbow. Like any other surgery, y...
What is the current status of trial NCT01328782?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2008-06. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01328782?
The interventions under investigation include: Bupivacaine 0.25% (DRUG), Oxycodone with Acetaminophen (DRUG), Ropivacaine 0.20% (DRUG).
Who is sponsoring clinical trial NCT01328782?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.